SPP1+ TAMs were described in 8 cancer subtypes: BC, PCA, Lung, CRC, Uterine corpus endometrial, Nasopharyngeal, Ovarian and Thyroid carcinoma, preferentially expressing an angiogenic signature (19). Here, SPP1 is linked to cancer.